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Dental Abnormalities in Schimke 
Immuno-osseous Dysplasia
ORIGINAL REPORT
Abstract: Described for the first time 
in 1971, Schimke immuno-osseous 
dysplasia (SIOD) is an autosomal-
recessive multisystem disorder that 
is caused by bi-allelic mutations of 
SMARCAL1, which encodes a DNA 
annealing helicase. To define better the 
dental anomalies of SIOD, we reviewed 
the records from SIOD patients 
with identified bi-allelic SMARCAL1 
mutations, and we found that 66.0% 
had microdontia, hypodontia, or 
malformed deciduous and permanent 
molars. Immunohistochemical analyses 
showed expression of SMARCAL1 
in all developing teeth, raising the 
possibility that the malformations 
are cell-autonomous consequences of 
SMARCAL1 deficiency. We also found 
that stimulation of cultured skin 
fibroblasts from SIOD patients with the 
tooth morphogens WNT3A, BMP4, and 
TGFβ1 identified altered transcriptional 
responses, raising the hypothesis that 
the dental malformations arise in part 
from altered responses to developmental 
morphogens. To the best of our 
knowledge, this is the first systematic 
study of the dental anomalies 
associated with SIOD.
Key Words: SMARCAL1, tooth morpho-
genesis, microdontia, hypodontia, molar 
root hypoplasia, cell signaling.
Introduction
Schimke immuno-osseous 
dysplasia (SIOD, OMIM 242900) is 
an autosomal-recessive disorder in 
which the prominent features are 
spondyloepiphyseal dysplasia, renal 
dysfunction, T-cell immunodeficiency, 
and facial dysmorphism (Schimke et al., 
1971; Spranger et al., 1991; Boerkoel 
et al., 2000). The dysmorphic features 
include a triangular face, broad nasal 
bridge, bulbous nose tip, small palpebral 
fissures, dental anomalies, a short neck, 
hyperpigmented macules, protuberant 
trunk, and short limbs. Those with 
severe disease usually die within the 
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first decade, whereas those with milder 
disease can survive into adulthood.
The only known cause of SIOD is 
bi-allelic mutations of the SMARCAL1 gene 
(Boerkoel et al., 2002). This gene encodes 
a protein from the sucrose non-fermenting 
2 (SNF2) family that functions as a 
DNA annealing helicase (Yusufzai and 
Kadonaga, 2008). SMARCAL1 participates 
in the DNA stress response, the processing 
of stalled DNA replication forks, and gene 
expression (Bansbach et al., 2009; Ciccia 
et al., 2009; Postow et al., 2009; Yuan  
et al., 2009; Yusufzai et al., 2009; 
Baradaran-Heravi et al., 2012; Bétous  
et al., 2012). Alterations in gene 
expression correlate with disease in SIOD 
patients and model organisms (Baradaran-
Heravi et al., 2012).
Prior studies suggest a cell-autonomous 
mechanism for many features of SIOD. 
First, mouse SMARCAL1 is expressed in 
all tissues analogous to those affected 
in SIOD (Elizondo et al., 2006). Second, 
SIOD-specific renal failure does not recur 
in the renal grafts of transplanted SIOD 
patients (Boerkoel et al., 2000; Clewing 
et al., 2007a). Third, arterial disease 
characteristic of SIOD does not affect the 
renal grafts of SIOD patients (Lücke  
et al., 2004; Clewing et al., 2007a). 
Fourth, bone marrow transplant does 
not prevent renal failure, and renal 
transplantation does not prevent arterial 
disease among SIOD patients (Boerkoel 
et al., 2000; Petty et al., 2000).
Since the formation of the teeth 
proceeds via a series of precisely 
orchestrated molecular and morphogenic 
events (Jernvall and Thesleff, 2000), 
we hypothesized that the anomalies 
identified in SIOD patients give 
insight into the role of SMARCAL1 
during development. We therefore 
profiled the dental anomalies 
observed in SIOD patients, defined 
the expression of SMARCAL1 in the 
developing anlagen, and tested the 
consequences of SMARCAL1 deficiency 
on the transcriptional responses 
to the developmental morphogens 
wingless-type MMTV integration site 
family member 3A (WNT3A), bone 
morphogenetic protein 4 (BMP4), and 
transforming growth factor b 1 (TGFb1).
Materials & Methods
Patients
Patients referred to this study gave 
informed consent to a protocol 
approved by the Institutional Review 
Board of Baylor College of Medicine 
(Houston, TX, USA), the Hospital for 
Sick Children (Toronto, ON, Canada), 
or the University of British Columbia 
(Vancouver, BC, Canada). Autopsy tissues 
were obtained according to the protocol 
approved by the University of British 
Columbia (Vancouver, BC, Canada). 
The clinical data were obtained from 
the referring physician. Patients were 
grouped according to disease severity 
as previously described (Clewing et al., 
2007b).
Immunohistochemistry
Heat-induced epitope retrieval was 
conducted with sodium citrate buffer 
(10 mM sodium citrate, 0.05% Tween 20, 
pH 6). Endogenous peroxidases were 




 for 30 min. 
Sections were first blocked with blocking 
buffer [20% normal goat serum, 10% 
bovine serum albumin, casein (SP-5020, 
Vector Laboratories, Burlington, ON, 
Canada), 0.2% Triton X-100, 1X PBS, pH 
7.4], and then incubated with rabbit anti-
SMARCAL1 serum (1:200) (Kilic  
et al., 2005) diluted in blocking buffer, 
each overnight at 4°C. The sections 
were washed and then incubated with 
biotinylated anti-rabbit IgG (1:200, 
BA-1000, Vector Laboratories). Then 
sections were washed and incubated 
with avidin biotinylated horseradish 
peroxidase complex (PK-6100, Vector 
Laboratories). Immune complexes were 
visualized with 3,3′-diaminobenzidine 
(Dako, Mississauga, ON, Canada), and 
sections were counterstained with 
Mayer’s Hematoxylin (Sigma, Oakville, 
ON, Canada). The staining of adjacent 
sections with pre-immune serum was 
used to confirm antiserum specificity 
(Figs. 2c, 2d, 2g, 2h, 2k, and 2l).
Morphogen Induction of 
Patient Dermal Fibroblasts
Forty-eight hrs prior to WNT3A, BMP4, 
or TGFb1 treatment, 5 × 104 cells were 
seeded in each well of a 24-well plate. 
Twenty-four hrs prior to morphogen 
addition, growth media were replaced 
with serum-free media. Cells were treated 
with 100 ng/mL WNT3A, 50 ng/mL 
BMP4, or 4 ng/mL TGFb1 (R&D Systems, 
Minneapolis, MN, USA) for 0, 2, 4, 8, 12, 
16, 20, or 24 hrs. For each time-point 
and treatment, 3 parallel cultures were 
analyzed for each cell line.
RNA Isolation and Reverse 
Transcription
RNA was extracted from cells with the 
the RNeasy 96 Kit (Qiagen, Toronto, 
ON, Canada), and on-column DNase 
I digestion (Qiagen) was performed 
to remove genomic DNA. Reverse 
transcription was performed with the 
qScript™ cDNA Synthesis Kit (Quanta 
Biosciences, Gaithersburg, MD, USA) 
according to the manufacturer’s 
specifications.
Quantitative PCR
SsoFastTM EvaGreen® Supermix (Bio-Rad 
Laboratories, Mississauga, ON, Canada) 
was used with the ABI StepOnePlusTM 
Real-Time PCR System. Expression of 
the housekeeping gene GAPDH was 
used as the internal control. The primer 
sequences used in this study are listed in 
Appendix Table 1.
Statistics
Graphed quantitative data are presented 
as mean ± standard deviation of a 
minimum of 3 independent replicates. 
The relative quantification of gene 
expression was calculated by the 2–∆∆Ct 
method (Livak and Schmittgen, 2001). 
The DC
t
 of the unaffected control cell 
line was used as the calibrator for relative 
basal gene expression, and the DC
t
 of 
the cell line of interest at time 0 hrs was 
used as the calibrator for relative gene 
expression over time. Standard deviations 
were calculated from the triplicate 
samples at each time-point after the 
2–∆∆Ct transformations were performed. 
Data were analyzed by one-way analysis 
of variance (ANOVA), followed by 
the Tukey post hoc test for multiple 
comparisons between cell lines or time-
points, with SPSS Statistics (version 20, 
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IBM). A p-value of less than 0.05 was 
considered statistically significant.
Results
Developmental Tooth Anomalies 
Are a Common Feature of SIOD
Among SIOD patients with identified 
bi-allelic SMARCAL1 mutations, 66.0% of 
patients had dental anomalies. For those 
patients for whom records were obtained, 
46.8% had microdontia and 52.3% had 
hypodontia (Table and Appendix Table 2). 
The number of missing teeth ranged from 
15 to 0, and the premolars were most 
frequently absent (Appendix Table 2).
Besides small or absent teeth, 72.0% of 
SIOD patients had molar root hypoplasia 
(Appendix Table 2). The disproportion 
between the molar crown and root 
ranged from severe in SD38, SD57, 
SD60, SD74 and SD119 to nearly normal 
in SD18c (Figs. 1a-1f). The permanent 
premolars and first molars were 
commonly malformed, while the incisors 
and canines were usually normally 
shaped (Figs. 1a-1l, Appendix Fig. 1).
For the one patient (SD60) for 
whom we received photographs and 
radiographs at multiple developmental 
ages, both the deciduous and permanent 
dentitions were affected (Figs. 1g-1l). 
As shown for SD60, most had teeth of 
normal color and opacity (Figs. 1g-1l).
SMARCAL1 Is Highly Expressed 
in the Developing Human Tooth
To determine if SMARCAL1 was 
expressed in the tooth anlagen, we 
obtained post mortem tissue from 
59-day-, 98-day-, and 105-day-gestation 
fetuses and assessed expression by 
immunohistochemistry. SMARCAL1 was 
expressed in all cell types throughout 
the bud, cap, and bell stages (Figs. 2a, 
2b, 2e, 2f, 2i, and 2j; Appendix Table 
3). Compared with the oral epithelium, 
SMARCAL1 expression was moderate 
to strong in the outer and inner dental 
epithelia and primary enamel knot, 
moderate in the stellate reticulum, and 
weak in the dental papilla and dental 
lamina (Figs. 2a, 2b, 2e, 2f, 2i, and 2j; 
Appendix Table 3).
Observing that the premolars and 
molars were generally more affected 
than the anterior teeth, we hypothesized 
that SMARCAL1 was not expressed 
in the anterior teeth. However 
immunohistochemical analysis of post 
mortem tissue from a 98-day-gestation 
fetus showed that SMARCAL1 was 
strongly expressed in the incisor, canine, 
and premolar anlagen as well as in the 
tooth bud of the permanent premolar 
(Appendix Fig. 2).
SIOD Tooth Anomalies Are Distinct 
from Other Disorders of DNA Repair
The known function of SMARCAL1 in 
DNA repair and replication suggests that 
SMARCAL1 deficiency in the proliferating 
Table.
Summary of Dental Findings in SIOD Patients with Bi-allelic SMARCAL1 Mutations
Affected Individuals/Total Reported (Percentage)






















Missing permanent premolar (1) 



































Abnormal superior incisors (1) 
Delayed dentition (1)
aPatients were grouped according to disease severity as described (Clewing et al., 2007b).
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Figure 1.
Photographs and dental x-rays showing the dental pathology of patients with identified bi-allelic SMARCAL1 mutations. (a-f) Radiographic 
appearance of the teeth of six SIOD patients. The small white arrows indicate a retained deciduous molar in SD18c (a) and SD27 (b); 
the white asterisk indicates a missing permanent premolar in SD74 (e). (g-i) Physical (g) and radiographic (h and i) appearance of the 
deciduous teeth of patient SD60. (j-l) Physical (j) and radiographic (k and l) appearance of the permanent teeth of patient SD60. Note 
that the microdontia, thin molar roots, and bulbous molar crowns are evident in both the deciduous and permanent teeth. The large white 
arrows indicate the bulbous molar crowns in SD60 at 7 yrs of age (i) and 13 yrs of age (l); the small grey arrows indicate the thin molar 
roots in SD60 at 7 yrs of age (i) and 13 yrs of age (l). Abbreviation: yo, years old.
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tooth could lead to cell death or reduced 
proliferation. To test this hypothesis, we 
checked the viability and proliferation 
of dermal fibroblasts cultured from 
two SIOD patients. Dermal fibroblasts 
expressed SMARCAL1 mRNA and protein 
(Figs. 3a-3c), and fibroblasts from 
SD120 and SD123 exhibited viability 
and proliferation rates similar to those 
from an unaffected control (Fig. 3d). 
Additionally, we profiled the reported 
dental features of DNA repair and 
genomic instability disorders. Although 
microdontia, hypodontia, and short molar 
roots have been reported for Rothmund-
Thomson syndrome, Fanconi anemia, 
Seckel syndrome, and dyskeratosis 
congenita (Appendix Table 4), those 
teeth are distinct from those of SIOD. 
Together, these observations suggested to 
us that the dental anomalies observed in 
Figure 2.
Analysis of SMARCAL1 protein expression during tooth morphogenesis. (a, b) Photomicrographs of SMARCAL1 immunohistochemical 
staining of the bud stage of tooth development. SMARCAL1 is expressed in the cells of the oral epithelium, dental lamina, and the 
mesenchymal cells, which give rise to the dental papilla. (c, d) Photomicrographs of pre-immune staining of the bud stage of tooth 
development. The cells of the oral epithelium, dental lamina, and mesenchymal cells showed minimal non-specific staining. (e, f) 
Photomicrographs of SMARCAL1 immunohistochemical staining of the cap stage of tooth development. SMARCAL1 is expressed in the 
cells of the dental lamina, outer dental epithelium, stellate reticulum, inner dental epithelium, primary enamel knot, and dental papilla.  
(g, h) Photomicrographs of pre-immune staining of the cap stage of tooth development. The cells of the dental lamina, outer dental 
epithelium, stellate reticulum, inner dental epithelium, primary enamel knot, and dental papilla did not show non-specific staining. (i, j) 
Photomicrographs of SMARCAL1 immunohistochemical staining of the bell stage of tooth development. SMARCAL1 is expressed in 
the cells of the outer dental epithelium, stellate reticulum, stratum intermedium, inner dental epithelium, and dental papilla. (k, l) 
Photomicrographs of pre-immune staining of the bell stage of tooth development treated with pre-immune rabbit serum. The cells of 
the dental lamina, outer dental epithelium, stellate reticulum, stratum intermedium, inner dental epithelium, and dental papilla showed 
minimal non-specific staining. The boxed regions correspond to the higher-magnification images. Abbreviations: DL, dental lamina; DP, 
dental papilla; EK, primary enamel knot; IDE, inner dental epithelium; MC, mesenchymal cells; ODE, outer dental epithelium; OE, oral 
epithelium; SI, stratum intermedium; SR, stellate reticulum. Scale bars: 50 mm.
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Figure 3.
Expression of SMARCAL1 in cultured human dermal fibroblasts and dysregulated transcriptional responses of SIOD patient dermal fibroblasts 
upon stimulation with BMP4 or TGFb1. (a) Photomicrographs showing immunofluorescence of SMARCAL1 (red), fibroblast marker prolyl 
4-hydroxylase (green), and DAPI (blue) in cultured human dermal fibroblasts. (b) Photograph of an immunoblot showing expression of 
SMARCAL1 protein in cultured human dermal fibroblasts. (c) Photograph of an agarose gel of RT-PCR products showing expression of 
SMARCAL1 mRNA in human dermal fibroblasts (+RT). A ‘no reverse transcription’ negative control (–RT) shows that there is no detectable 
genomic DNA contamination. (d) The relative cell viability and proliferation rates for SD120 and SD123 patient fibroblast cell lines are graphed 
relative to unaffected control fibroblasts. (e) The relative basal gene expression levels of fibroblasts from an unaffected control (white bars) 
and patients SD120 (light grey bars) and SD123 (dark grey bars) were measured by qRT-PCR. Expression of housekeeping gene GAPDH was 
used as the internal control; expression of each gene was first normalized to GAPDH expression and then graphed relative to the expression 
of the unaffected control. Error bars represent one standard deviation. * = p < 0.05. (f) The transcriptional responses of fibroblasts from 
an unaffected control (white bars) and patients SD120 (light grey bars) and SD123 (dark grey bars) were measured by qRT-PCR following 
induction with the indicated morphogens for 0, 2, 4, 8, 12, 16, 20, or 24 hrs. Expression of housekeeping gene GAPDH was used as the 
internal control; expression of each gene was first normalized to GAPDH expression and then graphed relative to its expression in the relevant 
cell line at time = 0 hrs. Error bars represent one standard deviation. Abbreviations: bp, base pairs, Cnt, control; DAPI, 4′6-diamidino-2-
phenylindole; h, hours; kDa, kilodalton; RT, reverse transcription. * = p < 0.05. Scale bars = 10 µm.
35S
JDR Clinical Research Supplementvol. 91 • suppl no. 1
SIOD might not arise predominantly from 
impaired DNA repair or slowing of the 
cell cycle.
WNT3A, BMP4, and TGFb1 Signaling 
Is Altered in Cultured SIOD Fibroblasts
Since SMARCAL1 interacts with 
transcriptionally active chromatin and 
modulates gene expression (Baradaran-
Heravi et al., 2012), and is expressed 
in major signaling centers coordinating 
tooth development (Jernvall and Thesleff, 
2000), we hypothesized that SMARCAL1 
deficiency alters transcriptional responses 
to morphogens acting on or secreted 
by these centers. However, we do not 
have dental cells derived from SIOD 
patients, and knockdown of SMARCAL1 
does not readily recapitulate the features 
of SIOD (Baradaran-Heravi et al., 
2012); therefore, in an initial attempt to 
address this question, we asked whether 
SMARCAL1 deficiency cell-autonomously 
altered transcriptional responses to 3 
morphogens involved in tooth formation 
in mice (Vainio et al., 1993; Unda et al., 
2001; Plikus et al., 2005; Hosoya et al., 
2008; Liu et al., 2008; Ahn et al., 2010) 
and for which transcriptional responses 
have been defined in dermal fibroblasts: 
WNT3A, BMP4, and TGFb1 (Appendix 
Table 5). By qRT-PCR, morphogen 
treatment induced expression of all target 
genes analyzed in the unaffected control 
fibroblasts (Figs. 3e, 3f, Appendix Fig. 3), 
and SMARCAL1 deficiency altered the 
basal expression and induction of several 
targets (Figs. 3e, 3f, Appendix Figs. 3, 
4, Appendix Tables 6, 7). Compared 
with control, BMP4 and TGFb1 did not 
induce expression of ID1 and MMP10, 
respectively (Fig. 3f, Appendix Table 
7). Less dramatically, but nonetheless 
significant, induction of PRDM6 
expression by WNT3A was less than 
observed in the control, and induction of 
SMAD6 and SMAD7 expression by TGFb1 
was premature compared with that in 
the control (Appendix Fig. 4, Appendix 
Table 7).
Discussion
This first comprehensive review of the 
dental anomalies in SIOD shows that 
66.0% of patients with bi-allelic mutations 
of SMARCAL1 have tooth anomalies and 
demonstrates that the SMARCAL1 protein 
is highly expressed in the developing 
human tooth. Furthermore, as a potential 
explanation for the cell-autonomous 
nature of the pathology, this study shows 
that SMARCAL1 deficiency significantly 
altered some gene expression responses 
to the tooth morphogens WNT3A, BMP4, 
and TGFb1  in cultured SIOD dermal 
fibroblasts.
As suggested by da Fonseca (2000), the 
dental phenotype in SIOD resembles that 
of dentinogenesis imperfecta (DI) type 
II, which is characterized by opalescent 
or translucent teeth with discoloration, 
increased attrition, short constricted roots, 
and obliteration of the pulp chambers 
(Shields et al., 1973). Also, like SIOD, 
DI type II affects both the deciduous 
and permanent dentition (Sclare, 1948). 
However, unlike DI type II, SIOD teeth 
infrequently have discoloration, enamel 
hypoplasia, and soft dentin, and the 
teeth of all SIOD patients reported 
herein had normal opacity. To the best 
of our knowledge; therefore, the dental 
phenotype of SIOD is unique.
The expression of SMARCAL1 in the 
outer and inner dental epithelia and 
primary enamel knot suggests that its 
deficiency could cell-autonomously 
cause the root and crown malformations 
of SIOD. Within the developing mouse 
tooth root, the outer and inner dental 
epithelia extend apically to give rise 
to the cervical loop and ultimately to 
Hertwig’s epithelial root sheath, which 
contributes to root development by 
inducing differentiation of mesenchymal 
cells into odontoblasts and cementoblasts 
(Zeichner-David et al., 2003). Within 
the developing crown, primary and 
secondary enamel knots regulate the size 
and shape of the crown (Jernvall and 
Thesleff, 2000).
In addition to its role in DNA repair 
and replication, SMARCAL1 modulates 
gene expression (Baradaran-Heravi et al., 
2012). Although the mechanism by which 
it does this is unknown, its annealing 
helicase activity might modulate the 
DNA architecture of gene promoters. 
In bacteria, promoter superhelicity is a 
major regulator of basal and inductive 
transcription (Pruss and Drlica, 1989; 
Hatfield and Benham, 2002). According 
to this model, deficiency of SMARCAL1 
alters the helicity of DNA in regulatory 
regions and promoters, and this 
inappropriately impedes or fosters the 
binding of transcription factors regulating 
responses to stimuli such as morphogens.
In this model, the tooth malformations 
observed in SIOD would arise by 
cell-autonomous alterations in the 
transcriptional responses to dental 
morphogens such as WNT3A, TGFb1, 
and BMP4. BMP4 is expressed in pre-
odontoblasts adjacent to the root sheath 
epithelium (Yamashiro et al., 2003); 
TGFb1 and WNT3A are expressed by 
the cervical loop (Vaahtokari et al., 
1991; Suomalainen and Thesleff, 2010); 
and BMP4 and TGFb1 are expressed 
by the enamel knot (Vaahtokari et al., 
1991; Åberg et al., 2004). WNT signaling 
regulates tooth number, size, and shape 
(Liu et al., 2008; Ahn et al., 2010). 
BMP4 mediates inductive epithelial-
mesenchymal interactions (Vainio et al., 
1993), regulates the formation of enamel 
knots (Thesleff et al., 2001) as well as 
Hertwig’s epithelial root sheath (Hosoya 
et al., 2008), and modulates tooth 
number, size, and shape (Plikus et al., 
2005). TGFb1 also modulates odontoblast 
differentiation (Unda et al., 2001). 
Substantiation of this model, however, 
requires extensive additional studies.
A finding not explained by this model 
is why SMARCAL1 deficiency affects 
molars more severely than anterior teeth. 
One possible speculation is that the 
more complex development of molars, 
which require the induction of secondary 
and tertiary enamel knots (Jernvall and 
Thesleff, 2000; Luukko et al., 2003), 
renders the molar more susceptible to the 
consequences of SMARCAL1 deficiency 
on transcriptional responses to tooth 
morphogens. Alternatively, SMARCAL1 
deficiency may not affect the expression 
of required genes in the developing 
anterior teeth as much as it does in the 
developing molar root. Future studies 
will test these speculations and define the 
differential dependence of developing 
molars on SMARCAL1 function.
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Furthermore, the failure of BMP4 
and TGFb1 to appropriately induce 
expression of some target genes in 
SIOD patient–derived dermal fibroblasts 
is consistent with other observations 
of SIOD. First, supplemental growth 
hormone fails to improve growth rate 
and stature for 93% of SIOD patients 
(C.F.B., unpublished observations; 
Boerkoel et al., 2000). Second, 40-50% 
of patients have a decreased response to 
thyroid-stimulating hormone and require 
levothyroxine supplementation (Boerkoel 
et al., 2000). Third, the bone marrow 
failure and anemia associated with SIOD 
frequently do not respond to treatment 
with stem cell factor and erythropoietin, 
respectively (Boerkoel et al., 2000).
In summary, our findings show that 
dental anomalies are common among 
SIOD patients and that SMARCAL1 is 
highly expressed in the developing tooth. 
Furthermore, the finding that SMARCAL1 
deficiency alters transcriptional responses 
to morphogens in cultured fibroblasts 
suggests a mechanism for the dental 
pathology of SIOD. These observations 
also provide a model for understanding 
how SMARCAL1 deficiency could give 
rise to other malformations characteristic 
of SIOD.
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